LogicMark, Inc. Reports Fourth Quarter and Full Year 2023 Results
April 18, 2024 09:00 ET
|
LogicMark, Inc.
LOUISVILLE, Ky., April 18, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the...
Qlik Sets the Pace for Real-World AI Business Transformations Across Industries
April 16, 2024 08:30 ET
|
Qlik Technologies, Inc.
Empowering Businesses to Embark on AI with Ease, Qlik also Introduces a Rapid-Deployment AI Accelerator PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- Qlik®, a global leader in data integration,...
Penn Highlands Healthcare Urges the Community: Help Save Lives. Become an Organ Donor
April 11, 2024 09:39 ET
|
Penn Highlands Healthcare
DuBois, PA, April 11, 2024 (GLOBE NEWSWIRE) -- Hope comes in all shapes and sizes and everyone has different wishes. Some people desire a new vehicle, a relaxing vacation or to fulfill their career...
LogicMark, Inc. Reschedules Release of Fourth Quarter and Full Year 2023 Financial Results to April 1, 2024
March 27, 2024 09:00 ET
|
LogicMark, Inc.
LogicMark, Inc. has rescheduled its Q4 2023 earnings call and release of financial results from March 27, 2024, to April 1, 2024.
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
March 27, 2024 07:00 ET
|
EDAP TMS S.A.
Record Q4 2023 total revenue of EUR 19.6 million ($21.3 million USD) increased 24.8% over Q4 2022Record Q4 2023 HIFU revenue of EUR 7.5 million ($8.1 million USD), an increase of 38.8% over Q4...
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
March 13, 2024 07:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Wednesday, March 27th at 8:30am EDT LYON, France, March 13, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 06, 2024 07:00 ET
|
EDAP TMS S.A.
LYON, France, March 6, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled...
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
March 04, 2024 07:00 ET
|
EDAP TMS S.A.
Focal One HIFU has potential to address large market impacting thousands of women each year LYON, France, March 4, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based...
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
February 29, 2024 07:00 ET
|
EDAP TMS S.A.
Record full-year 2023 preliminary unaudited revenue of EUR 60.4 million ($65.4 million USD), an increase of 9.6% over full-year 2022, driven by 31.7% HIFU growth Record Q4 2023 preliminary unaudited...
NBME Acquires MedVR Education to Enhance Assessment for Medical Professionals
February 15, 2024 10:17 ET
|
NBME
PHILADELPHIA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- NBME, a leading medical assessment organization, announces the successful asset acquisition of MedVR Education, an extended reality (XR) platform for...